Bruker Applied Mass Spectrometry Showcases Front-Line Chromatography-Free MS Screening at SOFT 2025

Chromatography-Free Forensic Kits Enhance Drug Screening Capabilities, and the Lab Accelerator Program Facilitates Rapid Method and Technology Adoption

PORTLAND, OR, USA - October 29, 2025 - Bruker Applied Mass Spectrometry will highlight advances in harmonized sample preparation for chromatography-free forensic screening across oral fluid, urine, and blood at the Annual Meeting of the Society of Forensic Toxicologists (SOFT) 2025 in Portland, demonstrating DART-MS technology on the EVOQ® DART-TQ⁺ system. The approach overcomes immunoassay screening limitations and challenges, and also adds the advantage of both the fast screen and legally defensible LC-MS confirmation, efficiently done on the same mass spectrometer.

A key focus is the PinPoint Testing DART-ToxBox® Kit, designed for the EVOQ DART-TQ⁺ and validated to ANSI/ASB Standard 036. The kit delivers accuracy, specificity, and sensitivity that outperforms traditional immunoassays, while allowing labs to reflex to LC-MS/MS confirmation on the same instrument. Applications include impaired driving, workplace testing, and bio-surveillance.

Attendees can learn about the Lab Accelerator Program, which helps labs adopt pre-optimized consumables, which minimizes time and effort, speeding up the adoption of new methods and technology.

Bruker will also present the timsMetabo™, bringing on ion-mobility separation to lower mass ranges relevant to drugs of abuse, improving isomer resolution and reducing matrix effects in complex biological samples.

Visit us at Booth #204 or request a demo to explore how these solutions can accelerate your toxicology workflows.

Media Contact

Nora Williams
Marketing and Communications Director
Bruker Applied Mass Spectrometry


E: nora.williams@bruker.com

For Research Use Only. Not for Use in Clinical Diagnostic Procedures.